Study | Sample sizea(% men) | Age, yearsb | Diagnoses | Disease severityb | |||
---|---|---|---|---|---|---|---|
SAPS III | SOFA | APACHE III | Other | ||||
Abdellaoui et al.[42] | C: 6 (100%) | C: 67(59–72) | COPD |  |  |  | C: FEV1 of 15(10–27)% |
N: 9 (78%) | N: 59(57–69) |  |  |  |  | N: FEV1 of 25(17–41)% | |
Gerovasili et al.[25] | C: 13 (62%) | C: 56(19) | Sepsis | C: 61(14) | C: 8(3) | C: 18(6) | Â |
N: 13 (46%) | N: 59(23) | Trauma | N: 66(9) | N: 10(3) | N: 19(3) | Â | |
 |  | Neurologic |  |  |  |  | |
Gruther et al.[43] | C(A): 9 (89%) | C(A): 48(12) | Polytrauma | Â | Â | Â | Â |
N(A): 8 (88%) | N(A): 52(10) | Cardiovascular | Â | Â | Â | Â | |
C(L): 8 (50%) | C(L): 64(8) | Transplant | Â | Â | Â | Â | |
N(L): 8 (88%) | N(L): 61(10) | Pneumonia | Â | Â | Â | Â | |
 |  | Cancer |  |  |  |  | |
C: 28 (79%) | C: 59(21) | Sepsis | C: 58(14) | C: 8(3) | C: 19(5) | C: 39% with CIPNM | |
N: 24 (79%) | N: 55(20) | Trauma | N: 55(11) | N: 8(3) | N: 16(4) | N: 13% with CIPNM | |
 |  | Post-surgery |  |  |  |  | |
 |  | Brain injury |  |  |  |  | |
 |  | Respiratory failure |  |  |  |  | |
Poulsen et al.[44] | C/N: 8 (100%) | C/N: 67(64–72) | Sepsis |  | C/N: 11(9–14) | C/N: 25(20–29) | C/N: 13(10–22) days in ICU |
RodrÃguez et al.[45]c | C/N: 14 (50%) | C/N: 72(63–80) | Sepsis |  | C/N: 10(9–12) | C/N: 20(18–27) | C/N: 27(19–44) days in ICU |
Zanotti et al.[46] | C: 12 (67%) | C: 65(4) | COPD | Â | Â | Â | C: 47(19) days in ICU |
N: 12 (75%) | N: 66(8) | Â | Â | Â | Â | N: 52(15) days in ICU |